KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Gains from Investment Securities (2016 - 2025)

Novavax has reported Gains from Investment Securities over the past 16 years, most recently at $5.0 million for Q4 2025.

  • Quarterly results put Gains from Investment Securities at $5.0 million for Q4 2025, up 1526.3% from a year ago — trailing twelve months through Dec 2025 was $8.8 million (up 827.92% YoY), and the annual figure for FY2025 was $8.8 million, up 827.92%.
  • Gains from Investment Securities for Q4 2025 was $5.0 million at Novavax, down from $8.5 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for NVAX hit a ceiling of $121.9 million in Q4 2021 and a floor of -$9.0 million in Q2 2021.
  • Median Gains from Investment Securities over the past 5 years was $1.4 million (2024), compared with a mean of $11.6 million.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 4236.64% in 2021 and later tumbled 338.35% in 2024.
  • Novavax's Gains from Investment Securities stood at $121.9 million in 2021, then tumbled by 60.87% to $47.7 million in 2022, then plummeted by 99.87% to $62000.0 in 2023, then surged by 396.77% to $308000.0 in 2024, then skyrocketed by 1526.3% to $5.0 million in 2025.
  • The last three reported values for Gains from Investment Securities were $5.0 million (Q4 2025), $8.5 million (Q3 2025), and -$6.2 million (Q2 2025) per Business Quant data.